| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Research Officer | Senior Vice President, R&D | Senior Vice President, R&D
1 company
Rote William E. serves as a Chief Research Officer at TVTX. Across recent SEC filings that breaks down to 0 buys and 59 sells. Those positions are worth an estimated $6.2M at current prices.
Historically, Rote William E.'s trades have earned a middling insider score of 58/100 across 20 rated trades. Over a 12-month horizon, 44.4% of those trades were profitable, with an average 12-month return of -15.7%.
The biggest single holding is TVTX (~$6.2M) as Chief Research Officer. The recent filings there lean toward selling, a net 385,539 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 16, 2026 | TVTX Travere Therapeutics, Inc. | Chief Research Officer | Sale+OE10b5-1 | 209,048 | $62.83 | $13,135,397.45 | -68.0% | - | - | |
| May 6, 2026 | TVTX Travere Therapeutics, Inc. | Chief Research Officer | Sale+OE10b5-1 | 2,763 | $43.95 | $121,433.85 | -2.3% | +25.2% | - | |
| Apr 22, 2026 | TVTX Travere Therapeutics, Inc. | Chief Research Officer | Sell10b5-1 | 9,100 | $39.09 | $355,719.00 | -7.4% | +41.1% | - | |
| Feb 3, 2026 | TVTX Travere Therapeutics, Inc. | Chief Research Officer | Sell10b5-1 | 12,446 | $32.87 | $409,100.02 | -10.2% | +36.8% | - | |
| Dec 24, 2025 | TVTX Travere Therapeutics, Inc. | Chief Research Officer | Sale+OE10b5-1 | 60,000 | $40.10 | $2,406,180.00 | -37.2% | -33.5% | - | |
| May 5, 2025 | TVTX Travere Therapeutics, Inc. | Chief Research Officer | Sale+OE10b5-1 | 3,198 | $21.05 | $67,317.90 | -3.1% | -25.5% | +109.2% | |
| Feb 12, 2025 | TVTX Travere Therapeutics, Inc. | Senior Vice President, R&D | Sale+OE10b5-1 | 5,200 | $23.53 | $122,356.00 | -5.0% | -9.7% | +31.9% | |
| Feb 3, 2025 | TVTX Travere Therapeutics, Inc. | Senior Vice President, R&D | Sell10b5-1 | 8,951 | $19.78 | $177,050.78 | -8.6% | +5.9% | +62.4% | |
| Jan 22, 2025 | TVTX Travere Therapeutics, Inc. | Senior Vice President, R&D | Sell10b5-1 | 2,437 | $19.46 | $47,424.02 | -2.8% | -18.4% | +52.8% | |
| Sep 9, 2024 | TVTX Travere Therapeutics, Inc. | Senior Vice President, R&D | Sell10b5-1 | 4,387 | $11.52 | $50,538.24 | -4.9% | +46.0% | +68.3% |